医药生物行业跟踪周报:2026版基药目录调整在即 利好拟纳入目录的中药标的

东吴证券
Mar 01

本周(2.24-2.27,下同)、年初至今A 股医药指数涨幅分别为0.5%、3.0%,相对沪深300 的超额收益分别为-0.6%、1.2%;本周、年初至今恒生生物科技指数涨跌幅分别为-6.1%、7.2%,相对于恒生科技指数的超额收益分别为-4.6%、-6.9%;本周生物制品(+2.6%)、医疗器械(+2.2%)、原料药(+1.9%)涨幅较大,化学制药(-0.6%)、医疗服务(-1.0%)等跌幅较大...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10